arketamine nasal spray (HR071603)
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 16, 2022
A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=50 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Recruiting ➔ Completed
Trial completion • CNS Disorders • Depression • Mood Disorders • Psychiatry
1 to 1
Of
1
Go to page
1